Claims that HIV has been permanently eradicated from people living with the virus are false. More research, refined delivery ...

Researchers evaluated the prevalence of low-level viremia and its influence on the risk for virologic failure in patients with HIV on antiretroviral therapy.

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...

Landmark study on HIV antibodies b12 and bNAbs, their challenges, and regional effectiveness, emphasizing global HIV research importance.

Decades into the battle against HIV-1, scientists are increasingly focused on a remarkable class of infection-fighting ...

Charlie revealed he was HIV positive in 2015 and stayed quiet about his personal life for years, until he gave a health update in 2023.

SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the “Company”), a ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 demonstrated potent virus-neutralizing ability by targeting a difficult-to-reach ...

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus” or the "Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer ...

Thus, starting ART soon after diagnosis of HIV infection protects people’s health—it is good fro the user as well as the partner. These findings are likely to affect many countries’ guidelines for ...